An international collaboration between Bostonian biotech company, CureLab Oncology, and East European country, Belarus, may save lives of cancer patients on both continents and around the world

MINSK, BELARUS—August 3, 2021: The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen™, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer. Continue reading “An international collaboration between Bostonian biotech company, CureLab Oncology, and East European country, Belarus, may save lives of cancer patients on both continents and around the world”